quarterly

Well that should put a lot of people's doubts to rest

$1M+ of cash and cash equivalents - no capital raising

The company does not expect to raise further capital this quarter as material transactions are in progress which are not reflected in the current share price. Analytica’s cash equivalents are in excess of $1.0M which is sufficient for the next two quarters.

- draft distribution agreement received from CBS

- 14 hospitals tested positive in Brazil, expanding the survey for the distribution agreement to include more - nice

- Late last year a major multinational supplier of medical devices in the United States requested some of our AutoStart Burettes for testing purposes by their engineers. Analytica sent burettes made in our new manufacturing facility in China and after rigorous testing were passed by their engineers. Marketing efforts are continuing with this company and we are hopeful of further developments.